Atlas Trials

A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese Subjects

Clinical trial NCT06449703 · UNKNOWN

Trial details

NCT number
NCT06449703
Sponsor
Tonghua Dongbao Pharmaceutical Co.,Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2024-05-06
Primary completion
2024-06-16
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.